ACHN

Achillion Appoints Nicholas Simon to Board of Directors - 08/20 - 04:00 PM ET

ACHN: To Present At Canaccord Adams Global Growth Conference @ 16:30 ET [delayed] - 08/13 - 02:53 PM ET

Achillion Reports Second Quarter 2008 Financial Results - 08/12 - 04:00 PM ET

Achillion to Present At Canaccord Adams Global Growth Conference - 08/12 - 07:01 AM ET

Achillion Pharmaceuticals Inc declares private placement of units - 08/07 - 04:58 AM ET

ACHN: To Present At Needham Bio & Medical Tech Conference @ 11:30 ET [delayed] - 06/11 - 09:53 AM ET

ACHN: Additional Positive Phase 2 Data for Elvucitabine in HIV - 06/09 - 08:52 AM ET

Achillion Announces Additional Positive Top-Line Phase 2 Data for Elvucitabine - 06/09 - 07:00 AM ET

Achillion nominates new candidate from HCV protease program - 06/06 - 09:32 AM ET

Achillion Nominates ACH-1625 as Lead Candidate in Proprietary Program Targeting HCV Protease - 06/04 - 04:07 PM ET

Achillion to Present At Needham Biotechnology Conference - 05/23 - 07:30 AM ET

Achillion Pharmaceuticals, Inc. (ACHN) Corporate Event Announcement Notice - 05/08 - 09:09 PM ET

Achillion Pharmaceuticals, Inc. (ACHN) Corporate Event Announcement Notice - 05/08 - 08:38 PM ET

Achillion Pharmaceuticals, Inc. (ACHN) Corporate Event Announcement Notice - 05/07 - 08:38 PM ET

Achillion Reports First Quarter 2008 Financial Results - 05/07 - 05:15 PM ET

Achillion Pharmaceuticals, Inc. (ACHN) Corporate Event Announcement Notice - 05/06 - 08:37 PM ET

Achillion Pharmaceuticals, Inc. (ACHN) Corporate Event Announcement Notice - 05/05 - 08:38 PM ET

Achillion and FOB Synthesis sign research collaboration - 04/09 - 09:38 AM ET

Achillion and FOB Synthesis Announce Collaboration for the Development of Carbapenem Compounds - 04/08 - 07:45 AM ET

Achillion To Present At Cowen And Company 28th Annual Health Care Conference; Webcast At 3:15 PM - 03/17 - 02:45 PM ET

Page 1 of 3     1  2   3      Previous  |  Next

<< Back to Stock Index